Recent 8-K filings for BDPT

• March 18, 2025, 7:59 PM ET other material materiality 0.55 positive item 7.01item 9.01

  BioAdaptives' Zeranovia weight loss product shows 5-7 lbs/week loss in dosage trial

  Participants lost 5–7 pounds per week in Zeranovia dosage trial.

• February 7, 2025, 6:59 PM ET leadership materiality 0.55 positive item 5.02item 9.01 ◈ executive_change ×2

  BioAdaptives appoints Mark Frissora (ex-Hertz CEO) to board, Reed Harris (UFC exec) to advisory board

  Mark Frissora, former Chairman/CEO of Hertz and Caesars Entertainment, appointed to Board of Directors on Feb 3, 2025.

• December 5, 2024, 6:59 PM ET dividend materiality 0.50 neutral item 7.01item 9.01

  BioAdaptives declares one-for-one stock dividend payable in January 2025

  One additional common share for each share owned as of the record date.

• November 27, 2024, 6:59 PM ET other material materiality 0.65 positive item 7.01item 9.01

  BioAdaptives gets IRB approval for human trial of weight management product Zeranovia

  IRB approved human clinical trial for Zeranovia, a weight management supplement.

• November 20, 2024, 6:59 PM ET other material materiality 0.60 neutral item 8.01item 7.01item 9.01

  BioAdaptives completes 1-for-300 reverse stock split effective Nov 21, 2024

  Reverse split reduces outstanding shares from ~1.23B to ~4.1M.

• October 30, 2024, 7:59 PM ET other material materiality 0.55 neutral item 7.01item 9.01

  BioAdaptives plans reverse stock split after shares balloon 6,530% in 5 years; CEO cites turnaround

  Shares outstanding grew from 18.6M (Jan 2020) to 1.23B (June 2024), a 6,530% increase with no revenue growth.

• May 22, 2024, 7:59 PM ET leadership materiality 0.70 neutral item 7.01item 9.01

  BioAdaptives appoints James Keener as new CEO and Chairman; Jacobs and Ellis resign

  Edward Jacobs resigned as Chairman and CEO; Robert Ellis resigned as director and President, both for personal reasons.

• May 14, 2024, 7:59 PM ET regulatory materiality 0.60 negative item 4.01 ◈ Auditor Changes ×2

  BioAdaptives dismisses auditor BF Borgers after SEC permanent suspension; appoints Boladale Lawal & Co

  SEC permanently suspended BF Borgers from practicing as accountants and PCAOB auditors on SEC filings, effective May 3, 2024.

• April 6, 2023, 7:59 PM ET other material materiality 0.50 neutral item 5.02item 5.03item 9.01 ◈ executive_change◈ Governance Changes

  BioAdaptives appoints Dr. Yaguang Liu to board and increases authorized shares to 1.25 billion

  Dr. Yaguang Liu appointed to board effective April 5, 2023; holds 32 US patents on natural botanicals.

• June 14, 2022, 7:59 PM ET other materiality 0.35 positive item 7.01item 9.01

  BioAdaptives sponsors COVID long-hauler survey; offers senior discount pricing

  Sponsors COVID long hauler survey with Dr. Regina Sutton; provides free PluriPain, PrimiLungs, PrimiSleep.

• February 3, 2022, 6:59 PM ET other material materiality 0.60 positive item 1.01item 7.01item 9.01

  BioAdaptives acquires exclusive option to buy oxygenated-water patent, forms MORO2 subsidiary

  Exclusive two-year option to purchase U.S. Patent 9,783,432B for $400,000.

• January 21, 2022, 6:59 PM ET other material materiality 0.50 positive item 7.01item 9.01

  BioAdaptives signs LOI to acquire U.S. Patent 9,783,432B for oxygenated water tech

  LOI with inventor Thomas J. Mohr to acquire rights to patent covering enhanced-oxygen water.

• December 16, 2021, 6:59 PM ET other material materiality 0.50 neutral item 7.01item 9.01

  BioAdaptives enters marketing agreement for LungFlute medical device; plans LungArmor package

  Marketing agreement with Acoustic Innovations LLC for LungFlute™ OscPEP device; rights in US, Canada, and other approved regions.

• August 27, 2021, 7:59 PM ET other material materiality 0.35 positive item 7.01item 9.01

  BioAdaptives partners with Stanford professor to study PluriPain for Gadolinium Deposition Disease pain

  Collaboration with Stanford's Prof. Lorrin Koran to research PluriPain for pain relief in Gadolinium Deposition Disease.

• July 22, 2021, 7:59 PM ET other material materiality 0.10 neutral item 8.01item 9.01

  BioAdaptives Livestock Impact Division launches Ambassador Program for equine supplement marketing

  Ambassador Program provides affiliate marketing support, social media placement, and discounts for industry participants.

Executive changes

Materiality & sentiment trend

Max materiality 0.70 · Median 0.55 · Most common event other_material

7 positive 1 negative 7 neutral

source · BDPT on sec.gov